Difference between revisions of "Libre Pathology:Libre Pathology at two years"
(7 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
[[Image:Libre Pathology - logo - white background.png|250px|thumb|The Libre Pathology logo.]] | [[Image:Libre Pathology - logo - white background.png|250px|thumb|The Libre Pathology logo.]] | ||
Approximately '''[[Official launch of Libre Pathology|two years ago Libre Pathology]]''' was officially launched, coinciding with a pair of talks at the [[Libre Pathology:Presentations at the 2014 Annual Meeting of the Canadian Association of Pathologists| | Approximately '''[[Official launch of Libre Pathology|two years ago Libre Pathology]]''' was officially launched, coinciding with a pair of talks at the [[Libre Pathology:Presentations at the 2014 Annual Meeting of the Canadian Association of Pathologists|CAP-ACP meeting]]. | ||
Looking back at this past year, the site has grown considerably. We are delighted to say that visitors come from around the world, and that a subset of those visit regularly. | ==Looking back== | ||
Looking back at this past year, the site has grown considerably (see Table 1). We are delighted to say that visitors come from around the world, and that a subset of those visit regularly. | |||
Last year, we analysed the traffic to site and found that benign gynecologic pathology and dermatopathology are the pages with the most views. We also noted that significant traffic is on tablets/smart phones. | Last year, we analysed the traffic to the site and found that benign [[gynecologic pathology]] and [[dermatopathology]] are the pages with the most views. We also noted that significant traffic is on tablets/smart phones. | ||
Recently, | <center> | ||
{| class="wikitable" style="text-align: center;" | |||
|+'''Table 1: Visits to Libre Pathology '15/'16.''' | |||
|- | |||
! Time | |||
! Average visits <br>per month | |||
|- | |||
| Jul - Sep '15 | |||
| 22500 | |||
|- | |||
| Oct - Dec '15 | |||
| 26400 | |||
|- | |||
| Jan - Mar '16 | |||
| 30800 | |||
|- | |||
| Apr - Jun '16 | |||
| 31100 | |||
|} | |||
</center> | |||
Recently, the number of unique visitors per month was a bit less than 20k. | |||
In April and May, we did a survey for the first time. | |||
Beyond that, we still see great potential in many areas, and are looking for | ==Looking ahead== | ||
The preliminary findings of the [[Libre Pathology:Survey|survey]] will be presented at the [[Libre Pathology:ESP/IAP Congress 2016|European Society of Pathology/International Academy of Pathology meeting]] in September. | |||
Beyond that, we still see great potential in many areas, and are looking for ways to expand the community and reach of the project. | |||
==See also== | ==See also== | ||
*[[Libre Pathology news]]. | *[[Libre Pathology news]]. | ||
*[[Libre Pathology at one year]]. | *[[Libre Pathology at one year]]. | ||
[[Category:Libre Pathology news]] | [[Category:Libre Pathology news]] |
Latest revision as of 14:43, 14 July 2016
Approximately two years ago Libre Pathology was officially launched, coinciding with a pair of talks at the CAP-ACP meeting.
Looking back
Looking back at this past year, the site has grown considerably (see Table 1). We are delighted to say that visitors come from around the world, and that a subset of those visit regularly.
Last year, we analysed the traffic to the site and found that benign gynecologic pathology and dermatopathology are the pages with the most views. We also noted that significant traffic is on tablets/smart phones.
Time | Average visits per month |
---|---|
Jul - Sep '15 | 22500 |
Oct - Dec '15 | 26400 |
Jan - Mar '16 | 30800 |
Apr - Jun '16 | 31100 |
Recently, the number of unique visitors per month was a bit less than 20k.
In April and May, we did a survey for the first time.
Looking ahead
The preliminary findings of the survey will be presented at the European Society of Pathology/International Academy of Pathology meeting in September.
Beyond that, we still see great potential in many areas, and are looking for ways to expand the community and reach of the project.